SUNIL HEALTHCARE | STERLING BIOTECH | SUNIL HEALTHCARE/ STERLING BIOTECH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -59.6 | -0.0 | - | View Chart |
P/BV | x | 1.1 | 0.1 | 1,484.0% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
SUNIL HEALTHCARE STERLING BIOTECH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SUNIL HEALTHCARE Mar-24 |
STERLING BIOTECH Mar-18 |
SUNIL HEALTHCARE/ STERLING BIOTECH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 80 | 7 | 1,181.7% | |
Low | Rs | 46 | 2 | 2,783.5% | |
Sales per share (Unadj.) | Rs | 88.0 | 12.7 | 694.3% | |
Earnings per share (Unadj.) | Rs | -1.7 | -36.9 | 4.7% | |
Cash flow per share (Unadj.) | Rs | 4.2 | -27.9 | -15.0% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 66.6 | 10.1 | 656.6% | |
Shares outstanding (eoy) | m | 10.25 | 272.17 | 3.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.7 | 0.3 | 215.3% | |
Avg P/E ratio | x | -36.0 | -0.1 | 31,644.1% | |
P/CF ratio (eoy) | x | 15.0 | -0.2 | -9,951.5% | |
Price / Book Value ratio | x | 0.9 | 0.4 | 227.6% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 644 | 1,144 | 56.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 129 | 583 | 22.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 902 | 3,449 | 26.1% | |
Other income | Rs m | 52 | 55 | 94.9% | |
Total revenues | Rs m | 954 | 3,504 | 27.2% | |
Gross profit | Rs m | 41 | -7,582 | -0.5% | |
Depreciation | Rs m | 61 | 2,457 | 2.5% | |
Interest | Rs m | 58 | 4,397 | 1.3% | |
Profit before tax | Rs m | -26 | -14,381 | 0.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | -8 | -4,327 | 0.2% | |
Profit after tax | Rs m | -18 | -10,054 | 0.2% | |
Gross profit margin | % | 4.5 | -219.8 | -2.1% | |
Effective tax rate | % | 30.0 | 30.1 | 99.7% | |
Net profit margin | % | -2.0 | -291.5 | 0.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 625 | 4,807 | 13.0% | |
Current liabilities | Rs m | 573 | 56,226 | 1.0% | |
Net working cap to sales | % | 5.7 | -1,490.7 | -0.4% | |
Current ratio | x | 1.1 | 0.1 | 1,275.6% | |
Inventory Days | Days | 13 | 1,685 | 0.8% | |
Debtors Days | Days | 1,643 | 543 | 302.3% | |
Net fixed assets | Rs m | 960 | 65,836 | 1.5% | |
Share capital | Rs m | 103 | 272 | 37.7% | |
"Free" reserves | Rs m | 580 | 2,486 | 23.3% | |
Net worth | Rs m | 682 | 2,759 | 24.7% | |
Long term debt | Rs m | 203 | 19,787 | 1.0% | |
Total assets | Rs m | 1,585 | 70,643 | 2.2% | |
Interest coverage | x | 0.6 | -2.3 | -24.6% | |
Debt to equity ratio | x | 0.3 | 7.2 | 4.1% | |
Sales to assets ratio | x | 0.6 | 0 | 1,165.4% | |
Return on assets | % | 2.5 | -8.0 | -31.4% | |
Return on equity | % | -2.6 | -364.5 | 0.7% | |
Return on capital | % | 3.6 | -44.3 | -8.2% | |
Exports to sales | % | 17.7 | 22.8 | 77.7% | |
Imports to sales | % | 28.9 | 0.6 | 4,844.4% | |
Exports (fob) | Rs m | 160 | 785 | 20.3% | |
Imports (cif) | Rs m | 260 | 21 | 1,266.6% | |
Fx inflow | Rs m | 160 | 785 | 20.3% | |
Fx outflow | Rs m | 260 | 26 | 991.2% | |
Net fx | Rs m | -101 | 759 | -13.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -154 | -328 | 46.9% | |
From Investments | Rs m | -101 | -91 | 110.6% | |
From Financial Activity | Rs m | 250 | 384 | 65.1% | |
Net Cashflow | Rs m | -5 | -35 | 14.4% |
Indian Promoters | % | 73.5 | 24.6 | 298.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.1 | 21.9 | 0.5% | |
FIIs | % | 0.0 | 7.5 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 26.5 | 75.4 | 35.1% | |
Shareholders | 6,507 | 35,184 | 18.5% | ||
Pledged promoter(s) holding | % | 0.0 | 55.9 | - |
Compare SUNIL HEALTHCARE With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES GHCL
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | SUNIL HEALTHCARE | Sterling Biotech | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 2.24% | -4.94% | 0.67% |
1-Month | -9.55% | 6.94% | -3.33% |
1-Year | 49.08% | -78.61% | 43.33% |
3-Year CAGR | 24.41% | -46.43% | 19.82% |
5-Year CAGR | 34.88% | -32.29% | 26.27% |
* Compound Annual Growth Rate
Here are more details on the SUNIL HEALTHCARE share price and the Sterling Biotech share price.
Moving on to shareholding structures...
The promoters of SUNIL HEALTHCARE hold a 73.5% stake in the company. In case of Sterling Biotech the stake stands at 24.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUNIL HEALTHCARE and the shareholding pattern of Sterling Biotech.
Finally, a word on dividends...
In the most recent financial year, SUNIL HEALTHCARE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
Sterling Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of SUNIL HEALTHCARE, and the dividend history of Sterling Biotech.
For a sector overview, read our pharmaceuticals sector report.
On Tuesday, Indian share markets traded on a positive note throughout the session and ended marginally higher.